Edward M. MD Kaye
CIK 1522780 · CEO · last filed 2026-06-05
Edward M. MD Kaye is a CEO who has filed 116 SEC Form 4 insider transactions across 6 companies since 2011. The most recent filing, for STOK, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$18.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.20M
6
116
-$18.32M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STOK | Director | 110,874 | $29.82 | $3.31M | -$8.05M | 36 | 2026-06-05 |
| CYTK | Director | 10,283 | $70.15 | $721.4K | -$5.51M | 50 | 2026-06-01 |
| Avidity Biosciences, Inc. (RNAM) Delisted | Director | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Director | 6,692 | $12.37 | $82.8K | $0 | 5 | 2025-06-12 |
| SRPT | President & CEO | 71,229 | $15.31 | $1.09M | -$4.77M | 22 | 2017-08-07 |
| Sarepta Therapeutics, Inc. (AVII) Delisted | SVP & Chief Medical Officer | — | — | — | $0 | 2 | 2012-04-25 |
Recent Filings
116 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | STOK | Grant (A) | — | $0 | EDGAR |
| 2026-06-01 | CYTK | Sell (S) | −2,933 | -$223.2K | EDGAR |
| 2026-05-27 | CYTK | Grant (A) | +2,851 | $0 | EDGAR |
| 2026-04-15 | CYTK | Grant (A) | +191 | $12.5K | EDGAR |
| 2026-03-17 | STOK | Exer (M) | +61,750 | $0 | EDGAR |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) Delisted | Disp (D) | −6,692 | $0 | EDGAR |
| 2026-01-16 | CYTK | Grant (A) | +197 | $12.5K | EDGAR |
| 2025-12-10 | STOK | Sell (S) | −13,430 | -$433.4K | EDGAR |
| 2025-12-05 | STOK | Mixed | +11,249 | -$467.0K | EDGAR |
| 2025-12-03 | STOK | Mixed | +2,181 | -$64.5K | EDGAR |